Icecure Medical Ltd is a pioneering medical technology company that specializes in the development and commercialization of innovative treatments for cancer using its proprietary cryoablation technology
This minimally invasive approach involves the use of extreme cold to target and destroy cancerous cells while preserving surrounding healthy tissue. The company focuses on providing effective solutions for a range of tumors, positioning its products to improve patient outcomes and enhance the overall experience of cancer treatment. Through ongoing research and collaboration with healthcare professionals, Icecure aims to advance the field of oncology and offer patients safer, less invasive alternatives to traditional therapies.
New Standard of Care? IceCure Submits Final ICE3 Data To FDA, Minimally Invasive Cryoablation Shows Similar 5-year Recurrence Outcomes To Surgery With Hormone Therapy
Companies Reporting Before The Bell • Acuity Brands (NYSE:AYI) is projected to report quarterly earnings at $3.25 per share on revenue of $907.75 million.
CAESAREA, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) -- IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure” or the “Company”), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it has received a written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities, including the Company's ordinary shares, to maintain a minimum bid price of $1.00 per share.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Tuesday. The Dow traded up 0.27% to 35,429.20 while the NASDAQ rose 0.12% to 14,258.32. The S&P 500 also rose, gaining, 0.07% to 4,553.52.
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.
Gainers Maris-Tech Ltd. (NASDAQ: MTEK) shares rose 38% to $1.38 in pre-market trading, after gaining 6% on Friday. Maris-Tech, on Friday, disclosed the launch of Jupiter Drones, an innovative, drone-oriented solution based on Maris-Tech's Jupiter Nano platform.
Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq.
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling more than 150 points on Monday. The Dow traded down 0.49% to 33,344.27 while the NASDAQ rose 0.21% to 13,246.63. The S&P 500 also fell, dropping, 0.40% to 4,271.07.
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations.
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 40 points on Monday. The Dow traded down 0.60% to 33,306.79 while the NASDAQ rose 0.29% to 13,257.86. The S&P 500 also fell, dropping, 0.40% to 4,270.74.
IceCure Medical Ltd (NASDAQ: ICCM) announced that new data was presented at the European Society of Breast Imaging Scientific Meeting, validating IceCure's ProSense Cryoablation is a safe and effective outpatient procedure for breast cancer with a
U.S. stocks traded mixed this morning, with the Dow Jones falling around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.31% to 33,404.26 while the NASDAQ rose 0.38% to 13,269.83. The S&P 500 also fell, dropping, 0.09% to 4,284.19.
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 200 points on Wednesday. The Dow traded up 0.59% to 34,720.69 while the NASDAQ fell 0.07% to 13,668.37. The S&P 500 also rose, gaining, 0.17% to 4,451.42.
